nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadodiamide—Gadoxetate—SLCO1B1—breast cancer	0.00902	0.541	CrCbGaD
Gadodiamide—Gadobenate Dimeglumine—ALB—breast cancer	0.00383	0.23	CrCbGaD
Gadodiamide—Gadofosveset trisodium—ALB—breast cancer	0.00383	0.23	CrCbGaD
Gadodiamide—Myalgia—Capecitabine—breast cancer	0.00031	0.000315	CcSEcCtD
Gadodiamide—Pain—Paclitaxel—breast cancer	0.00031	0.000315	CcSEcCtD
Gadodiamide—Pharyngitis—Methotrexate—breast cancer	0.000309	0.000314	CcSEcCtD
Gadodiamide—Anxiety—Capecitabine—breast cancer	0.000309	0.000314	CcSEcCtD
Gadodiamide—Urinary tract disorder—Methotrexate—breast cancer	0.000307	0.000313	CcSEcCtD
Gadodiamide—Anaphylactic shock—Docetaxel—breast cancer	0.000307	0.000312	CcSEcCtD
Gadodiamide—Oedema—Docetaxel—breast cancer	0.000307	0.000312	CcSEcCtD
Gadodiamide—Discomfort—Capecitabine—breast cancer	0.000306	0.000311	CcSEcCtD
Gadodiamide—Pruritus—Gemcitabine—breast cancer	0.000306	0.000311	CcSEcCtD
Gadodiamide—Nausea—Thiotepa—breast cancer	0.000305	0.00031	CcSEcCtD
Gadodiamide—Urethral disorder—Methotrexate—breast cancer	0.000305	0.00031	CcSEcCtD
Gadodiamide—Infection—Docetaxel—breast cancer	0.000305	0.00031	CcSEcCtD
Gadodiamide—Diarrhoea—Irinotecan—breast cancer	0.000304	0.000309	CcSEcCtD
Gadodiamide—Diarrhoea—Mitoxantrone—breast cancer	0.000304	0.000309	CcSEcCtD
Gadodiamide—Dry mouth—Capecitabine—breast cancer	0.000303	0.000308	CcSEcCtD
Gadodiamide—Shock—Docetaxel—breast cancer	0.000302	0.000307	CcSEcCtD
Gadodiamide—Nervous system disorder—Docetaxel—breast cancer	0.000301	0.000306	CcSEcCtD
Gadodiamide—Pruritus—Fluorouracil—breast cancer	0.000301	0.000306	CcSEcCtD
Gadodiamide—Visual impairment—Methotrexate—breast cancer	0.0003	0.000305	CcSEcCtD
Gadodiamide—Tachycardia—Docetaxel—breast cancer	0.000299	0.000305	CcSEcCtD
Gadodiamide—Feeling abnormal—Paclitaxel—breast cancer	0.000298	0.000303	CcSEcCtD
Gadodiamide—Oedema—Capecitabine—breast cancer	0.000297	0.000302	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Paclitaxel—breast cancer	0.000296	0.000301	CcSEcCtD
Gadodiamide—Diarrhoea—Gemcitabine—breast cancer	0.000296	0.000301	CcSEcCtD
Gadodiamide—Renal failure—Doxorubicin—breast cancer	0.000295	0.0003	CcSEcCtD
Gadodiamide—Infection—Capecitabine—breast cancer	0.000295	0.0003	CcSEcCtD
Gadodiamide—Neuropathy peripheral—Doxorubicin—breast cancer	0.000294	0.000299	CcSEcCtD
Gadodiamide—Dizziness—Irinotecan—breast cancer	0.000293	0.000298	CcSEcCtD
Gadodiamide—Shock—Capecitabine—breast cancer	0.000292	0.000297	CcSEcCtD
Gadodiamide—Rhinitis—Epirubicin—breast cancer	0.000292	0.000297	CcSEcCtD
Gadodiamide—Nervous system disorder—Capecitabine—breast cancer	0.000291	0.000296	CcSEcCtD
Gadodiamide—Diarrhoea—Fluorouracil—breast cancer	0.000291	0.000296	CcSEcCtD
Gadodiamide—Tinnitus—Methotrexate—breast cancer	0.00029	0.000295	CcSEcCtD
Gadodiamide—Tachycardia—Capecitabine—breast cancer	0.00029	0.000295	CcSEcCtD
Gadodiamide—Pharyngitis—Epirubicin—breast cancer	0.000289	0.000294	CcSEcCtD
Gadodiamide—Urinary tract disorder—Epirubicin—breast cancer	0.000288	0.000293	CcSEcCtD
Gadodiamide—Urticaria—Paclitaxel—breast cancer	0.000288	0.000292	CcSEcCtD
Gadodiamide—Hyperhidrosis—Capecitabine—breast cancer	0.000287	0.000292	CcSEcCtD
Gadodiamide—Hypotension—Docetaxel—breast cancer	0.000287	0.000292	CcSEcCtD
Gadodiamide—Body temperature increased—Paclitaxel—breast cancer	0.000286	0.000291	CcSEcCtD
Gadodiamide—Abdominal pain—Paclitaxel—breast cancer	0.000286	0.000291	CcSEcCtD
Gadodiamide—Urethral disorder—Epirubicin—breast cancer	0.000286	0.00029	CcSEcCtD
Gadodiamide—Vomiting—Irinotecan—breast cancer	0.000282	0.000287	CcSEcCtD
Gadodiamide—Vomiting—Mitoxantrone—breast cancer	0.000282	0.000287	CcSEcCtD
Gadodiamide—Dizziness—Fluorouracil—breast cancer	0.000281	0.000286	CcSEcCtD
Gadodiamide—Visual impairment—Epirubicin—breast cancer	0.000281	0.000285	CcSEcCtD
Gadodiamide—Rash—Irinotecan—breast cancer	0.00028	0.000285	CcSEcCtD
Gadodiamide—Rash—Mitoxantrone—breast cancer	0.00028	0.000285	CcSEcCtD
Gadodiamide—Dermatitis—Mitoxantrone—breast cancer	0.00028	0.000284	CcSEcCtD
Gadodiamide—Dermatitis—Irinotecan—breast cancer	0.00028	0.000284	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Docetaxel—breast cancer	0.00028	0.000284	CcSEcCtD
Gadodiamide—Chills—Methotrexate—breast cancer	0.000279	0.000284	CcSEcCtD
Gadodiamide—Headache—Mitoxantrone—breast cancer	0.000278	0.000283	CcSEcCtD
Gadodiamide—Headache—Irinotecan—breast cancer	0.000278	0.000283	CcSEcCtD
Gadodiamide—Hypotension—Capecitabine—breast cancer	0.000278	0.000282	CcSEcCtD
Gadodiamide—Paraesthesia—Docetaxel—breast cancer	0.000275	0.00028	CcSEcCtD
Gadodiamide—Vomiting—Gemcitabine—breast cancer	0.000275	0.00028	CcSEcCtD
Gadodiamide—Dyspnoea—Docetaxel—breast cancer	0.000274	0.000278	CcSEcCtD
Gadodiamide—Somnolence—Docetaxel—breast cancer	0.000273	0.000277	CcSEcCtD
Gadodiamide—Rash—Gemcitabine—breast cancer	0.000273	0.000277	CcSEcCtD
Gadodiamide—Dermatitis—Gemcitabine—breast cancer	0.000272	0.000277	CcSEcCtD
Gadodiamide—Tinnitus—Epirubicin—breast cancer	0.000272	0.000276	CcSEcCtD
Gadodiamide—Headache—Gemcitabine—breast cancer	0.000271	0.000275	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Capecitabine—breast cancer	0.000271	0.000275	CcSEcCtD
Gadodiamide—Flushing—Epirubicin—breast cancer	0.00027	0.000275	CcSEcCtD
Gadodiamide—Vomiting—Fluorouracil—breast cancer	0.00027	0.000275	CcSEcCtD
Gadodiamide—Rhinitis—Doxorubicin—breast cancer	0.00027	0.000275	CcSEcCtD
Gadodiamide—Dyspepsia—Docetaxel—breast cancer	0.00027	0.000275	CcSEcCtD
Gadodiamide—Rash—Fluorouracil—breast cancer	0.000268	0.000273	CcSEcCtD
Gadodiamide—Dermatitis—Fluorouracil—breast cancer	0.000268	0.000272	CcSEcCtD
Gadodiamide—Pharyngitis—Doxorubicin—breast cancer	0.000267	0.000272	CcSEcCtD
Gadodiamide—Paraesthesia—Capecitabine—breast cancer	0.000267	0.000271	CcSEcCtD
Gadodiamide—Hypersensitivity—Paclitaxel—breast cancer	0.000267	0.000271	CcSEcCtD
Gadodiamide—Headache—Fluorouracil—breast cancer	0.000266	0.000271	CcSEcCtD
Gadodiamide—Urinary tract disorder—Doxorubicin—breast cancer	0.000266	0.000271	CcSEcCtD
Gadodiamide—Dysgeusia—Methotrexate—breast cancer	0.000265	0.00027	CcSEcCtD
Gadodiamide—Dyspnoea—Capecitabine—breast cancer	0.000265	0.000269	CcSEcCtD
Gadodiamide—Fatigue—Docetaxel—breast cancer	0.000265	0.000269	CcSEcCtD
Gadodiamide—Urethral disorder—Doxorubicin—breast cancer	0.000264	0.000269	CcSEcCtD
Gadodiamide—Nausea—Irinotecan—breast cancer	0.000264	0.000268	CcSEcCtD
Gadodiamide—Nausea—Mitoxantrone—breast cancer	0.000264	0.000268	CcSEcCtD
Gadodiamide—Pain—Docetaxel—breast cancer	0.000262	0.000267	CcSEcCtD
Gadodiamide—Dyspepsia—Capecitabine—breast cancer	0.000261	0.000266	CcSEcCtD
Gadodiamide—Chills—Epirubicin—breast cancer	0.000261	0.000266	CcSEcCtD
Gadodiamide—Arrhythmia—Epirubicin—breast cancer	0.00026	0.000265	CcSEcCtD
Gadodiamide—Visual impairment—Doxorubicin—breast cancer	0.00026	0.000264	CcSEcCtD
Gadodiamide—Asthenia—Paclitaxel—breast cancer	0.00026	0.000264	CcSEcCtD
Gadodiamide—Nausea—Gemcitabine—breast cancer	0.000257	0.000261	CcSEcCtD
Gadodiamide—Fatigue—Capecitabine—breast cancer	0.000256	0.00026	CcSEcCtD
Gadodiamide—Pruritus—Paclitaxel—breast cancer	0.000256	0.00026	CcSEcCtD
Gadodiamide—Pain—Capecitabine—breast cancer	0.000254	0.000258	CcSEcCtD
Gadodiamide—Feeling abnormal—Docetaxel—breast cancer	0.000253	0.000257	CcSEcCtD
Gadodiamide—Nausea—Fluorouracil—breast cancer	0.000252	0.000257	CcSEcCtD
Gadodiamide—Ill-defined disorder—Methotrexate—breast cancer	0.000251	0.000256	CcSEcCtD
Gadodiamide—Tinnitus—Doxorubicin—breast cancer	0.000251	0.000256	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Docetaxel—breast cancer	0.000251	0.000255	CcSEcCtD
Gadodiamide—Flushing—Doxorubicin—breast cancer	0.00025	0.000254	CcSEcCtD
Gadodiamide—Dysgeusia—Epirubicin—breast cancer	0.000248	0.000253	CcSEcCtD
Gadodiamide—Diarrhoea—Paclitaxel—breast cancer	0.000248	0.000252	CcSEcCtD
Gadodiamide—Feeling abnormal—Capecitabine—breast cancer	0.000245	0.000249	CcSEcCtD
Gadodiamide—Malaise—Methotrexate—breast cancer	0.000244	0.000248	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Capecitabine—breast cancer	0.000243	0.000247	CcSEcCtD
Gadodiamide—Abdominal pain—Docetaxel—breast cancer	0.000243	0.000247	CcSEcCtD
Gadodiamide—Body temperature increased—Docetaxel—breast cancer	0.000243	0.000247	CcSEcCtD
Gadodiamide—Chills—Doxorubicin—breast cancer	0.000242	0.000246	CcSEcCtD
Gadodiamide—Arrhythmia—Doxorubicin—breast cancer	0.000241	0.000245	CcSEcCtD
Gadodiamide—Dizziness—Paclitaxel—breast cancer	0.000239	0.000243	CcSEcCtD
Gadodiamide—Urticaria—Capecitabine—breast cancer	0.000236	0.00024	CcSEcCtD
Gadodiamide—Ill-defined disorder—Epirubicin—breast cancer	0.000235	0.000239	CcSEcCtD
Gadodiamide—Body temperature increased—Capecitabine—breast cancer	0.000235	0.000239	CcSEcCtD
Gadodiamide—Abdominal pain—Capecitabine—breast cancer	0.000235	0.000239	CcSEcCtD
Gadodiamide—Convulsion—Methotrexate—breast cancer	0.000235	0.000239	CcSEcCtD
Gadodiamide—Myalgia—Methotrexate—breast cancer	0.000231	0.000235	CcSEcCtD
Gadodiamide—Chest pain—Methotrexate—breast cancer	0.000231	0.000235	CcSEcCtD
Gadodiamide—Arthralgia—Methotrexate—breast cancer	0.000231	0.000235	CcSEcCtD
Gadodiamide—Vomiting—Paclitaxel—breast cancer	0.00023	0.000234	CcSEcCtD
Gadodiamide—Dysgeusia—Doxorubicin—breast cancer	0.00023	0.000234	CcSEcCtD
Gadodiamide—Malaise—Epirubicin—breast cancer	0.000229	0.000233	CcSEcCtD
Gadodiamide—Rash—Paclitaxel—breast cancer	0.000228	0.000232	CcSEcCtD
Gadodiamide—Dermatitis—Paclitaxel—breast cancer	0.000228	0.000232	CcSEcCtD
Gadodiamide—Discomfort—Methotrexate—breast cancer	0.000228	0.000232	CcSEcCtD
Gadodiamide—Syncope—Epirubicin—breast cancer	0.000227	0.000231	CcSEcCtD
Gadodiamide—Headache—Paclitaxel—breast cancer	0.000227	0.000231	CcSEcCtD
Gadodiamide—Hypersensitivity—Docetaxel—breast cancer	0.000226	0.00023	CcSEcCtD
Gadodiamide—Loss of consciousness—Epirubicin—breast cancer	0.000223	0.000227	CcSEcCtD
Gadodiamide—Anaphylactic shock—Methotrexate—breast cancer	0.000221	0.000225	CcSEcCtD
Gadodiamide—Asthenia—Docetaxel—breast cancer	0.00022	0.000224	CcSEcCtD
Gadodiamide—Convulsion—Epirubicin—breast cancer	0.00022	0.000223	CcSEcCtD
Gadodiamide—Infection—Methotrexate—breast cancer	0.00022	0.000223	CcSEcCtD
Gadodiamide—Hypersensitivity—Capecitabine—breast cancer	0.000219	0.000223	CcSEcCtD
Gadodiamide—Ill-defined disorder—Doxorubicin—breast cancer	0.000218	0.000221	CcSEcCtD
Gadodiamide—Pruritus—Docetaxel—breast cancer	0.000217	0.000221	CcSEcCtD
Gadodiamide—Nervous system disorder—Methotrexate—breast cancer	0.000217	0.000221	CcSEcCtD
Gadodiamide—Myalgia—Epirubicin—breast cancer	0.000216	0.00022	CcSEcCtD
Gadodiamide—Arthralgia—Epirubicin—breast cancer	0.000216	0.00022	CcSEcCtD
Gadodiamide—Chest pain—Epirubicin—breast cancer	0.000216	0.00022	CcSEcCtD
Gadodiamide—Anxiety—Epirubicin—breast cancer	0.000215	0.000219	CcSEcCtD
Gadodiamide—Nausea—Paclitaxel—breast cancer	0.000215	0.000219	CcSEcCtD
Gadodiamide—Hyperhidrosis—Methotrexate—breast cancer	0.000214	0.000217	CcSEcCtD
Gadodiamide—Discomfort—Epirubicin—breast cancer	0.000213	0.000217	CcSEcCtD
Gadodiamide—Asthenia—Capecitabine—breast cancer	0.000213	0.000217	CcSEcCtD
Gadodiamide—Malaise—Doxorubicin—breast cancer	0.000212	0.000215	CcSEcCtD
Gadodiamide—Dry mouth—Epirubicin—breast cancer	0.000211	0.000215	CcSEcCtD
Gadodiamide—Syncope—Doxorubicin—breast cancer	0.00021	0.000214	CcSEcCtD
Gadodiamide—Pruritus—Capecitabine—breast cancer	0.00021	0.000214	CcSEcCtD
Gadodiamide—Diarrhoea—Docetaxel—breast cancer	0.00021	0.000213	CcSEcCtD
Gadodiamide—Anaphylactic shock—Epirubicin—breast cancer	0.000207	0.00021	CcSEcCtD
Gadodiamide—Oedema—Epirubicin—breast cancer	0.000207	0.00021	CcSEcCtD
Gadodiamide—Hypotension—Methotrexate—breast cancer	0.000207	0.00021	CcSEcCtD
Gadodiamide—Loss of consciousness—Doxorubicin—breast cancer	0.000206	0.00021	CcSEcCtD
Gadodiamide—Infection—Epirubicin—breast cancer	0.000206	0.000209	CcSEcCtD
Gadodiamide—Shock—Epirubicin—breast cancer	0.000204	0.000207	CcSEcCtD
Gadodiamide—Convulsion—Doxorubicin—breast cancer	0.000203	0.000207	CcSEcCtD
Gadodiamide—Diarrhoea—Capecitabine—breast cancer	0.000203	0.000207	CcSEcCtD
Gadodiamide—Nervous system disorder—Epirubicin—breast cancer	0.000203	0.000206	CcSEcCtD
Gadodiamide—Dizziness—Docetaxel—breast cancer	0.000203	0.000206	CcSEcCtD
Gadodiamide—Tachycardia—Epirubicin—breast cancer	0.000202	0.000205	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Methotrexate—breast cancer	0.000201	0.000205	CcSEcCtD
Gadodiamide—Hyperhidrosis—Epirubicin—breast cancer	0.0002	0.000203	CcSEcCtD
Gadodiamide—Chest pain—Doxorubicin—breast cancer	0.0002	0.000203	CcSEcCtD
Gadodiamide—Myalgia—Doxorubicin—breast cancer	0.0002	0.000203	CcSEcCtD
Gadodiamide—Arthralgia—Doxorubicin—breast cancer	0.0002	0.000203	CcSEcCtD
Gadodiamide—Anxiety—Doxorubicin—breast cancer	0.000199	0.000202	CcSEcCtD
Gadodiamide—Paraesthesia—Methotrexate—breast cancer	0.000199	0.000202	CcSEcCtD
Gadodiamide—Discomfort—Doxorubicin—breast cancer	0.000197	0.000201	CcSEcCtD
Gadodiamide—Dyspnoea—Methotrexate—breast cancer	0.000197	0.0002	CcSEcCtD
Gadodiamide—Somnolence—Methotrexate—breast cancer	0.000197	0.0002	CcSEcCtD
Gadodiamide—Dizziness—Capecitabine—breast cancer	0.000196	0.0002	CcSEcCtD
Gadodiamide—Dry mouth—Doxorubicin—breast cancer	0.000195	0.000199	CcSEcCtD
Gadodiamide—Vomiting—Docetaxel—breast cancer	0.000195	0.000198	CcSEcCtD
Gadodiamide—Dyspepsia—Methotrexate—breast cancer	0.000195	0.000198	CcSEcCtD
Gadodiamide—Rash—Docetaxel—breast cancer	0.000193	0.000197	CcSEcCtD
Gadodiamide—Hypotension—Epirubicin—breast cancer	0.000193	0.000197	CcSEcCtD
Gadodiamide—Dermatitis—Docetaxel—breast cancer	0.000193	0.000197	CcSEcCtD
Gadodiamide—Headache—Docetaxel—breast cancer	0.000192	0.000195	CcSEcCtD
Gadodiamide—Anaphylactic shock—Doxorubicin—breast cancer	0.000191	0.000195	CcSEcCtD
Gadodiamide—Oedema—Doxorubicin—breast cancer	0.000191	0.000195	CcSEcCtD
Gadodiamide—Fatigue—Methotrexate—breast cancer	0.000191	0.000194	CcSEcCtD
Gadodiamide—Infection—Doxorubicin—breast cancer	0.00019	0.000193	CcSEcCtD
Gadodiamide—Pain—Methotrexate—breast cancer	0.000189	0.000192	CcSEcCtD
Gadodiamide—Vomiting—Capecitabine—breast cancer	0.000189	0.000192	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Epirubicin—breast cancer	0.000189	0.000192	CcSEcCtD
Gadodiamide—Shock—Doxorubicin—breast cancer	0.000188	0.000192	CcSEcCtD
Gadodiamide—Nervous system disorder—Doxorubicin—breast cancer	0.000188	0.000191	CcSEcCtD
Gadodiamide—Rash—Capecitabine—breast cancer	0.000187	0.00019	CcSEcCtD
Gadodiamide—Dermatitis—Capecitabine—breast cancer	0.000187	0.00019	CcSEcCtD
Gadodiamide—Tachycardia—Doxorubicin—breast cancer	0.000187	0.00019	CcSEcCtD
Gadodiamide—Headache—Capecitabine—breast cancer	0.000186	0.000189	CcSEcCtD
Gadodiamide—Paraesthesia—Epirubicin—breast cancer	0.000186	0.000189	CcSEcCtD
Gadodiamide—Hyperhidrosis—Doxorubicin—breast cancer	0.000185	0.000188	CcSEcCtD
Gadodiamide—Dyspnoea—Epirubicin—breast cancer	0.000184	0.000188	CcSEcCtD
Gadodiamide—Somnolence—Epirubicin—breast cancer	0.000184	0.000187	CcSEcCtD
Gadodiamide—Nausea—Docetaxel—breast cancer	0.000182	0.000185	CcSEcCtD
Gadodiamide—Feeling abnormal—Methotrexate—breast cancer	0.000182	0.000185	CcSEcCtD
Gadodiamide—Dyspepsia—Epirubicin—breast cancer	0.000182	0.000185	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Methotrexate—breast cancer	0.000181	0.000184	CcSEcCtD
Gadodiamide—Hypotension—Doxorubicin—breast cancer	0.000179	0.000182	CcSEcCtD
Gadodiamide—Fatigue—Epirubicin—breast cancer	0.000178	0.000181	CcSEcCtD
Gadodiamide—Pain—Epirubicin—breast cancer	0.000177	0.00018	CcSEcCtD
Gadodiamide—Nausea—Capecitabine—breast cancer	0.000176	0.000179	CcSEcCtD
Gadodiamide—Urticaria—Methotrexate—breast cancer	0.000176	0.000179	CcSEcCtD
Gadodiamide—Abdominal pain—Methotrexate—breast cancer	0.000175	0.000178	CcSEcCtD
Gadodiamide—Body temperature increased—Methotrexate—breast cancer	0.000175	0.000178	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Doxorubicin—breast cancer	0.000174	0.000177	CcSEcCtD
Gadodiamide—Paraesthesia—Doxorubicin—breast cancer	0.000172	0.000175	CcSEcCtD
Gadodiamide—Dyspnoea—Doxorubicin—breast cancer	0.000171	0.000174	CcSEcCtD
Gadodiamide—Feeling abnormal—Epirubicin—breast cancer	0.000171	0.000173	CcSEcCtD
Gadodiamide—Somnolence—Doxorubicin—breast cancer	0.00017	0.000173	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Epirubicin—breast cancer	0.000169	0.000172	CcSEcCtD
Gadodiamide—Dyspepsia—Doxorubicin—breast cancer	0.000169	0.000171	CcSEcCtD
Gadodiamide—Fatigue—Doxorubicin—breast cancer	0.000165	0.000168	CcSEcCtD
Gadodiamide—Urticaria—Epirubicin—breast cancer	0.000164	0.000167	CcSEcCtD
Gadodiamide—Pain—Doxorubicin—breast cancer	0.000164	0.000167	CcSEcCtD
Gadodiamide—Body temperature increased—Epirubicin—breast cancer	0.000164	0.000166	CcSEcCtD
Gadodiamide—Abdominal pain—Epirubicin—breast cancer	0.000164	0.000166	CcSEcCtD
Gadodiamide—Hypersensitivity—Methotrexate—breast cancer	0.000163	0.000166	CcSEcCtD
Gadodiamide—Asthenia—Methotrexate—breast cancer	0.000159	0.000161	CcSEcCtD
Gadodiamide—Feeling abnormal—Doxorubicin—breast cancer	0.000158	0.00016	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Doxorubicin—breast cancer	0.000157	0.000159	CcSEcCtD
Gadodiamide—Pruritus—Methotrexate—breast cancer	0.000156	0.000159	CcSEcCtD
Gadodiamide—Hypersensitivity—Epirubicin—breast cancer	0.000152	0.000155	CcSEcCtD
Gadodiamide—Urticaria—Doxorubicin—breast cancer	0.000152	0.000155	CcSEcCtD
Gadodiamide—Abdominal pain—Doxorubicin—breast cancer	0.000151	0.000154	CcSEcCtD
Gadodiamide—Body temperature increased—Doxorubicin—breast cancer	0.000151	0.000154	CcSEcCtD
Gadodiamide—Diarrhoea—Methotrexate—breast cancer	0.000151	0.000154	CcSEcCtD
Gadodiamide—Asthenia—Epirubicin—breast cancer	0.000148	0.000151	CcSEcCtD
Gadodiamide—Pruritus—Epirubicin—breast cancer	0.000146	0.000149	CcSEcCtD
Gadodiamide—Dizziness—Methotrexate—breast cancer	0.000146	0.000149	CcSEcCtD
Gadodiamide—Diarrhoea—Epirubicin—breast cancer	0.000142	0.000144	CcSEcCtD
Gadodiamide—Hypersensitivity—Doxorubicin—breast cancer	0.000141	0.000143	CcSEcCtD
Gadodiamide—Vomiting—Methotrexate—breast cancer	0.000141	0.000143	CcSEcCtD
Gadodiamide—Rash—Methotrexate—breast cancer	0.000139	0.000142	CcSEcCtD
Gadodiamide—Dermatitis—Methotrexate—breast cancer	0.000139	0.000142	CcSEcCtD
Gadodiamide—Headache—Methotrexate—breast cancer	0.000139	0.000141	CcSEcCtD
Gadodiamide—Asthenia—Doxorubicin—breast cancer	0.000137	0.00014	CcSEcCtD
Gadodiamide—Dizziness—Epirubicin—breast cancer	0.000137	0.000139	CcSEcCtD
Gadodiamide—Pruritus—Doxorubicin—breast cancer	0.000135	0.000138	CcSEcCtD
Gadodiamide—Vomiting—Epirubicin—breast cancer	0.000132	0.000134	CcSEcCtD
Gadodiamide—Nausea—Methotrexate—breast cancer	0.000131	0.000134	CcSEcCtD
Gadodiamide—Diarrhoea—Doxorubicin—breast cancer	0.000131	0.000133	CcSEcCtD
Gadodiamide—Rash—Epirubicin—breast cancer	0.00013	0.000133	CcSEcCtD
Gadodiamide—Dermatitis—Epirubicin—breast cancer	0.00013	0.000133	CcSEcCtD
Gadodiamide—Headache—Epirubicin—breast cancer	0.00013	0.000132	CcSEcCtD
Gadodiamide—Dizziness—Doxorubicin—breast cancer	0.000127	0.000129	CcSEcCtD
Gadodiamide—Nausea—Epirubicin—breast cancer	0.000123	0.000125	CcSEcCtD
Gadodiamide—Vomiting—Doxorubicin—breast cancer	0.000122	0.000124	CcSEcCtD
Gadodiamide—Rash—Doxorubicin—breast cancer	0.000121	0.000123	CcSEcCtD
Gadodiamide—Dermatitis—Doxorubicin—breast cancer	0.000121	0.000123	CcSEcCtD
Gadodiamide—Headache—Doxorubicin—breast cancer	0.00012	0.000122	CcSEcCtD
Gadodiamide—Nausea—Doxorubicin—breast cancer	0.000114	0.000116	CcSEcCtD
